Well & Well Pharma

Well & Well Pharma, established in 2010, is a prominent entity within the pharmaceutical and healthcare sectors. As a subsidiary of Well & Well Pharma UK Ltd, the company specializes in the manufacturing of high-quality medicinal products, including tablets, capsules, and cephalosporin formulations. Operating with a focus on rigorous quality control, the firm adheres strictly to current Good Manufacturing Practices (cGMP) to ensure product efficacy and safety for its diverse client base.

The company maintains a robust operational footprint, managing two distinct locations to support its production requirements. Its primary facility, situated in the National Industrial Zone of Rawalpindi, Pakistan, spans 43,200 sq ft. This site is equipped with advanced manufacturing infrastructure and a dedicated quality assurance department, which has earned the organization significant recognition from the Ministry of Health for maintaining superior industry standards.

With a workforce of 500-1,000 employees, Well & Well Pharma continues to expand its influence across the Asia-Pacific region. The company generates annual revenue of $39.1M and currently serves over 125 customers, leveraging its technical expertise to meet evolving medical demands. Meet Well & Well Pharma's team to learn more about the leadership driving these operations. The firm remains committed to scaling its production pipeline while upholding the stringent regulatory requirements necessary for pharmaceutical excellence in the global market.